Ethionamide-induced gynecomastia

Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literatu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dixit, Ramakant, George, Jacob, Sharma, Arun K., chhabra, Naveen, Jangir, Suresh K., Mishra, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356967/
https://www.ncbi.nlm.nih.gov/pubmed/22629101
http://dx.doi.org/10.4103/0976-500X.95532
_version_ 1782233616563044352
author Dixit, Ramakant
George, Jacob
Sharma, Arun K.
chhabra, Naveen
Jangir, Suresh K.
Mishra, Vikas
author_facet Dixit, Ramakant
George, Jacob
Sharma, Arun K.
chhabra, Naveen
Jangir, Suresh K.
Mishra, Vikas
author_sort Dixit, Ramakant
collection PubMed
description Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed.
format Online
Article
Text
id pubmed-3356967
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33569672012-05-24 Ethionamide-induced gynecomastia Dixit, Ramakant George, Jacob Sharma, Arun K. chhabra, Naveen Jangir, Suresh K. Mishra, Vikas J Pharmacol Pharmacother Case Report Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3356967/ /pubmed/22629101 http://dx.doi.org/10.4103/0976-500X.95532 Text en Copyright: © Journal of Pharmacology and Pharmacotherapeutics http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Dixit, Ramakant
George, Jacob
Sharma, Arun K.
chhabra, Naveen
Jangir, Suresh K.
Mishra, Vikas
Ethionamide-induced gynecomastia
title Ethionamide-induced gynecomastia
title_full Ethionamide-induced gynecomastia
title_fullStr Ethionamide-induced gynecomastia
title_full_unstemmed Ethionamide-induced gynecomastia
title_short Ethionamide-induced gynecomastia
title_sort ethionamide-induced gynecomastia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356967/
https://www.ncbi.nlm.nih.gov/pubmed/22629101
http://dx.doi.org/10.4103/0976-500X.95532
work_keys_str_mv AT dixitramakant ethionamideinducedgynecomastia
AT georgejacob ethionamideinducedgynecomastia
AT sharmaarunk ethionamideinducedgynecomastia
AT chhabranaveen ethionamideinducedgynecomastia
AT jangirsureshk ethionamideinducedgynecomastia
AT mishravikas ethionamideinducedgynecomastia

Ejemplares similares